Maddy Newby
banner
maddynewby.bsky.social
Maddy Newby
@maddynewby.bsky.social
PhD student studying Viral Glycobiology at the University of Southampton in the Crispin lab
Reposted by Maddy Newby
Super excited by our new #glycotime preprint! A long-term project from my group with awesome collaborator @elisafadda.bsky.social

Regulation of N-glycosylation efficiency by eukaryotic oligosaccharyltransferase www.biorxiv.org/content/10.1...

thread below 👇
a cartoon drawing of a pitcher and cup of sugar on a table
ALT: a cartoon drawing of a pitcher and cup of sugar on a table
media.tenor.com
September 9, 2025 at 7:32 AM
Reposted by Maddy Newby
Regulation of N-glycosylation efficiency by eukaryotic oligosaccharyltransferase https://www.biorxiv.org/content/10.1101/2025.09.06.674603v1
September 7, 2025 at 5:45 AM
Reposted by Maddy Newby
Blood, sweat, and beers: investigating mosquito biting preferences amidst noise and intoxication in a cross-sectional cohort study at a large music festival https://www.biorxiv.org/content/10.1101/2025.08.21.671470v1
August 26, 2025 at 1:45 PM
Reposted by Maddy Newby
Reposted by Maddy Newby
Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein | PNAS www.pnas.org/doi/10.1073/...
Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein | PNAS
Hepatitis C virus (HCV) currently causes about one million infections and 240,000 deaths worldwide each year. To reach the goal set by the World He...
www.pnas.org
April 18, 2025 at 5:06 AM
Reposted by Maddy Newby
#bioRxiv support team in Southampton 😎! @emilyxlucas.bsky.social @maddynewby.bsky.social just FYI
💪🏻😊 @richardsever.bsky.social
March 31, 2025 at 7:02 PM
Reposted by Maddy Newby
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes https://www.biorxiv.org/content/10.1101/2025.01.08.632013v1
January 9, 2025 at 12:46 PM